MORPHOLOGICAL-CHANGES IN THE HUMAN ENDOCRINE PANCREAS INDUCED BY CHRONIC EXCESS OF ENDOGENOUS GLUCAGON

被引:6
作者
BANI, D
BILIOTTI, G
SACCHI, TB
机构
[1] UNIV FLORENCE,DEPT HUMAN ANAT & HISTOL,SECT HISTOL & ALLARA,V G PIERACCINI 6,I-50139 FLORENCE,ITALY
[2] UNIV FLORENCE,DEPT PHYSIOPATHOL,SURG SECT,I-50139 FLORENCE,ITALY
关键词
ISLET CELLS; GLUCAGONOMA; IMMUNOCYTOCHEMISTRY; ULTRASTRUCTURE; MORPHOMETRY;
D O I
10.1007/BF02899547
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The non-tumoral endocrine pancreas from a patient with elevated plasma levels of glucagon due to a malignant glucagonoma was studied immunocytochemically, ultrastructurally and morphometrically. Compared with normal pancreatic islets from control subjects, those of the pancreas from the patient with a glucagonoma showed an almost complete disappearance of A cells, a decrease in immunoreactive insulin in B cells associated with cytological features indicating enhanced synthesis and secretion of this hormone, and an increase in immunoreactive somatostatin and pancreatic polypeptide (PP) accompanied by unusually high numbers of D and PP cells. In addition, numerous B cells were found outside the islets, either forming microislets or scattered in the exocrine tissue (nesidioblastosis). The possible mechanisms involved in determining the changes in the secretory activity of B cells and the alterations in the cell composition of the islets are discussed.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 29 条
[1]  
AHREN B, 1987, ACTA MED SCAND, V221, P185
[2]   INVIVO INHIBITION OF GLUCAGON-SECRETION BY PARACRINE BETA-CELL ACTIVITY IN MAN [J].
ASPLIN, CM ;
PAQUETTE, TL ;
PALMER, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (01) :314-318
[3]   A MALIGNANT-TUMOR OF THE PANCREAS PRODUCING GLUCAGONOMA SYNDROME - COEXISTENCE OF GLUCAGON AND PANCREATIC-POLYPEPTIDE (PP) IN THE TUMOR-CELLS [J].
BANI, D ;
SACCHI, TB ;
BILIOTTI, G .
PANCREAS, 1989, 4 (04) :511-519
[4]   STIMULATION OF GLUCAGON-RELEASE BY ADDITION OF ANTI-SOMATOSTATIN SERUM TO ISLETS OF LANGERHANS INVITRO [J].
BARDEN, N ;
LAVOIE, M ;
DUPONT, A ;
COTE, J ;
COTE, JP .
ENDOCRINOLOGY, 1977, 101 (02) :635-638
[5]   INSULIN CONTROL OF GLUCAGON RELEASE FROM INSULIN-DEFICIENT RAT ISLETS [J].
BUCHANAN, KD ;
MAWHINNEY, WA .
DIABETES, 1973, 22 (11) :801-803
[6]   REGULATION OF A-CELL AND B-CELL FUNCTION BY INSULIN AND GLUCAGON [J].
FUJIMOTO, WY ;
ENSINCK, JW .
HORMONE AND METABOLIC RESEARCH, 1981, 13 (10) :547-550
[7]   INHIBITION OF PANCREATIC GLUCAGON-RELEASE BY SOMATOSTATIN - INVITRO [J].
IVERSEN, J .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1974, 33 (02) :125-129
[8]   INHIBITION OF GLUCAGON-SECRETION BY EXOGENOUS GLUCAGON IN THE ISOLATED, PERFUSED DOG PANCREAS [J].
KAWAI, K ;
UNGER, RH .
DIABETES, 1982, 31 (06) :512-515
[9]   COMPARISON OF THE EFFECTS OF GLUCAGON-LIKE PEPTIDE-1-(1-37) AND PEPTIDE-(7-37) AND GLUCAGON ON ISLET HORMONE-RELEASE FROM ISOLATED PERFUSED CANINE AND RAT PANCREASES [J].
KAWAI, K ;
SUZUKI, S ;
OHASHI, S ;
MUKAI, H ;
OHMORI, H ;
MURAYAMA, Y ;
YAMASHITA, K .
ENDOCRINOLOGY, 1989, 124 (04) :1768-1773
[10]   PANCREATIC SOMATOSTATIN IS A MEDIATOR OF GLUCAGON-INHIBITION BY HYPERGLYCEMIA [J].
KLAFF, LJ ;
TABORSKY, GJ .
DIABETES, 1987, 36 (05) :592-596